DRTS files Form 144 to sell 10,000 shares

Rhea-AI Filing Summary

DRTS submitted a Form 144 notice identifying a proposed sale of 10,000 ordinary shares through Oppenheimer & Co. Inc.

The filing also lists 87,500 restricted stock units dated 08/08/2021 and records a prior sale by Levy Raphi of 60,000 ordinary shares on 01/08/2026 for $404,674.46.

Insights

Securities Attorney

Routine resale notice; details show broker, share counts, and a recent insider sale.

The filing lists a proposed sale of 10,000 ordinary shares via Oppenheimer & Co., and documents 87,500 restricted stock units dated 08/08/2021. It also records a recent sale by Levy Raphi of 60,000 ordinary shares on 01/08/2026 for $404,674.46.

This appears procedural: cash‑flow treatment and timing for the proposed 10,000‑share sale are not stated in the excerpt. Subsequent filings or broker confirmations would show execution details and any issuer involvement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DRTS Form 144 list for proposed sales?

The filing lists a proposed sale of 10,000 ordinary shares through Oppenheimer & Co. The notice names the broker and records related securities and prior transactions visible in the excerpt.

Does the filing show any prior insider sales for DRTS?

Yes. The excerpt records a sale by Levy Raphi of 60,000 ordinary shares on 01/08/2026 for $404,674.46. This is noted in the "Securities Sold During The Past 3 Months" section.

Are there restricted awards disclosed in the DRTS excerpt?

The excerpt shows 87,500 restricted stock units dated 08/08/2021 listed under securities to be sold or referenced as issued. The filing ties these RSUs to that original grant date.

Who is the broker handling the proposed sale in the DRTS Form 144?

The broker named is Oppenheimer & Co. Inc., with an address at 85 Broad St., New York. The broker entry is listed alongside the 10,000 share line in the excerpt.

Does the Form 144 excerpt state the proceeds go to the issuer?

The excerpt does not state who will receive proceeds. The entry shows the broker and share counts but does not specify whether sale proceeds go to the issuer or selling holder.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 07:28 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968095
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alpha Tau Medical Ltd.
SEC File Number	001-41316
Address of Issuer	KIRYAT HAMADA 5 JERUSALEM ISRAEL 9777605
Phone	972-3-577-4115
Name of Person for Whose Account the Securities are To Be Sold	Levy Raphi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co Inc. 85 Broad St. New York NY 10004	10000	73950.00	70380570	02/25/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/08/2021	Restricted Stock Units	Issuer			87500	08/08/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Levy Raphi KIRYAT HAMADA 5 Jerusalem L3 9777605	Ordinary	01/08/2026	60000	404674.46

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 03/17/2025
Date of Notice	02/25/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Levy Raphi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)